The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Insulin and neurodegenerative disease: shared and specific mechanisms
Abstract
Insulin has functions in the brain and dysregulation of these functions may contribute to the expression of late-life neurodegenerative disease. We provide a brief summary of research on the influence of insulin on normal brain function. We then review evidence that perturbation of this role may contribute to the symptoms and pathogenesis of various neurodegenerative disorders, such as Alzheimer's disease, vascular dementia, Parkinson's disease, and Huntington's disease. We conclude by considering whether insulin dysregulation contributes to neurodegenerative disorders through disease-specific or general mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The localization of insulin receptors in the hippocampus and medial temporal cortex suggests that insulin and glucose homeostasis play a role in physiological memory functions through their effect on synaptic plasticity and cellular survival [110].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [110]
Citations
Cites
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,526
The Endocrine Regulation of Aging by Insulin-like Signals
Tatar, M., Bartke, A., & Antebi, A. (2003) · Science · doi:10.1126/science.1081447 · Cited by 1,327
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Insulin receptors are widely distributed in the central nervous system of the rat
Havránková, J., Roth, J., & Brownstein, M. (1978) · Nature · doi:10.1038/272827a0 · Cited by 1,116
Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes
Rulifson, E. J., Kim, S. K., & Nusse, R. (2002) · Science · doi:10.1126/science.1070058 · Cited by 1,064
Research works printed but not linked: 1
- Schobotz, 1976, Fatty acid patterns and glucose tolerance in Huntington's chorea, Res Exp Med (Berl), 167, 203
Cited by
Sorted by citations
Items 301–400 of 828
Duarte, A. I., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.044 · Cited by 49
Gupta, S. N., Yadav, K., Mantri, S. S., Singhal, N. K., Ganesh, S., & Sandhir, R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0985-0 · Cited by 48
Zong, W., Zeng, X., Chen, S., Chen, L., Zhou, L., Wang, X., Gao, Q., Zeng, G., Hu, K., & Ouyang, D. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.01.013 · Cited by 48
Gao, S., Chen, Y., Sang, F., Yang, Y., Xia, J., Li, X., Zhang, J., Chen, K., & Zhang, Z. (2019) · Diabetes · doi:10.2337/db19-0233 · Cited by 46
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
Marsh, C. A., Berent‐Spillson, A., Love, T., Persad, C. C., Pop‐Busui, R., Zubieta, J., & Smith, Y. R. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.02.054 · Cited by 51
Li, Y., Glotfelty, E. J., Karlsson, T. E., Fortuno, L. V., Harvey, B. K., & Greig, N. H. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15521 · Cited by 47
Impaired Glucose Tolerance in the R6/1 Transgenic Mouse Model of Huntington’s Disease
Josefsen, K. E., Nielsen, M. D., Jørgensen, K. H., Bock, T. G., Nørremølle, A., Sorensen, S. A., Naver, B., & Hasholt, L. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01629.x · Cited by 49
Parkinson’s Disease and Sugar Intake—Reasons for and Consequences of a Still Unclear Craving
Haas, J., Berg, D., Bosy‐Westphal, A., & Schaeffer, E. (2022) · Nutrients · doi:10.3390/nu14153240 · Cited by 46
Ketogenic diets and Ketone suplementation: A strategy for therapeutic intervention
Saris, C. G. J., & Timmers, S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.947567 · Cited by 50
Wang, J., Zhang, J., Yu, Z., Chung, S. K., & Xu, B. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102416 · Cited by 52
Hippocampal calcium dysregulation at the nexus of diabetes and brain aging
Thibault, O., Anderson, K. L., DeMoll, C., Brewer, L. D., Landfield, P. W., & Porter, N. M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.024 · Cited by 46
Gonzales, M. M., Tarumi, T., Eagan, D. E., Tanaka, H., Vaghasia, M., & Haley, A. P. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31825ff1de · Cited by 46
Glucose deprivation increases tau phosphorylation via P 38 mitogen‐activated protein kinase
Lauretti, E., & Praticò, D. (2015) · Aging Cell · doi:10.1111/acel.12381 · Cited by 46
Zhao, Z., Ho, L., Wang, J., Qin, W., Festa, E. D., Mobbs, C., Hof, P., Rocher, A., Masur, S., Haroutunian, V., et al. (2005) · The FASEB Journal · doi:10.1096/fj.05-4359fje · Cited by 36
PINK1 deficiency in β-cells increases basal insulin secretion and improves glucose tolerance in mice
Deas, E., Piipari, K., Machhada, A., Li, A., del Arroyo, A. G., Withers, D. J., Wood, N. W., & Abramov, A. Y. (2014) · Open Biology · doi:10.1098/rsob.140051 · Cited by 47
Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains
Ahn, K.-C., Learman, C. R., Dunbar, G. L., Maiti, P., Jang, W., Cheol, H., & Song, M.-S. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.05.002 · Cited by 45
Willette, A., Bendlin, B., Colman, R., Kastman, E. K., Field, A., Alexander, A., Sridharan, A., Allison, D., Anderson, R. M., Voytko, M., et al. (2012) · Diabetes · doi:10.2337/db11-1187 · Cited by 48
Gratuze, M., Khoury, N. B. E., Turgeon, A., Julien, C., Marcouiller, F., Morin, F., Whittington, R. A., Marette, A., Calon, F., & Planel, E. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.10.004 · Cited by 47
Variation in GIGYF2 is not associated with Parkinson disease
Nichols, W. C., Kissell, D., Pankratz, N., Pauciulo, M. W., Elsaesser, V. E., Clark, K., Halter, C. A., Rudolph, A., Wojcieszek, J., Pfeiffer, R. F., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000346517.98982.1b · Cited by 45
From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function
Medina‐Julio, D., Ramírez-Mejía, M. M., Córdova‐Gallardo, J., Peniche-Luna, E., Cantú-Brito, C. G., & Méndez‐Sánchez, N. (2024) · Medical Science Monitor · doi:10.12659/msm.943417 · Cited by 45
Priyadarshini, M., Kamal, M. A., Greig, N. H., Reale, M., Abuzenadah, A. M., Chaudhary, A., & Damanhouri, G. A. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800792767 · Cited by 43
Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
Moreira, P. I., Cardoso, S. M., Pereira, C., Santos, M. S., & Oliveira, C. R. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824651 · Cited by 44
Oral diabetes medication and risk of dementia in elderly patients with type 2 diabetes
Kim, J. Y., Ku, Y. S., Kim, H. J., Trinh, N. T., Kim, W., Jeong, B., Heo, T., Lee, M. K., & Lee, K. E. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.07.004 · Cited by 46
Sharma, S., & Taliyan, R. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1081-2 · Cited by 43
Raikwar, S. P., Kikkeri, N. S., Sakuru, R. C., Saeed, D., Zahoor, H., Premkumar, K., Mentor, S., Thangavel, R., Dubova, I., Ahmed, M. E., et al. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09849-y · Cited by 48
Bittencourt, A., Brum, P. O., Ribeiro, C. T., Gasparotto, J., Bortolin, R. C., de Vargas, A. R., Heimfarth, L., de Almeida, R. F., Moreira, J. C. F., de Oliveira, J., et al. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1831261 · Cited by 43
Pablo‐Fernández, E. D., Courtney, R. J., Rockliffe, A., Gentleman, S., Holton, J. L., & Warner, T. T. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12728 · Cited by 43
Moon, J. H., Lim, S. K., Han, J. W., Kim, K. M., Choi, S. H., Park, K. S., Kim, K. W., & Jang, H. C. (2015) · Stroke · doi:10.1161/strokeaha.114.008170 · Cited by 44
Mirza, Z., Kamal, M. A., buzenadah, A., Al-Qahtani, M., & Karim, S. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660154 · Cited by 42
Hypothermia mediates age-dependent increase of tau phosphorylation in db/db mice
Khoury, N. B. E., Gratuze, M., Petry, F. R., Papon, M.-A., Julien, C., Marcouiller, F., Morin, F., Nicholls, S. B., Calon, F., Hébert, S. S., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.005 · Cited by 42
Serum insulin‐like system alterations in patients with spinocerebellar ataxia type 3
Saute, J. A. M., da Silva, A. C. F., Muller, A. P., Hansel, G., de Mello, A. S., Maeda, F. K., Vedolin, L., Pereira, M. L. S., Souza, D. O., Arpa, J., et al. (2010) · Movement Disorders · doi:10.1002/mds.23428 · Cited by 45
Intranasal treatment of neurodegenerative diseases and stroke
Gómez, D. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/252 · Cited by 43
Maigler, F., Ladel, S., Flamm, J., Gänger, S., Kurpiers, B., Kiderlen, S., Völk, R., Hamp, C., Hartung, S., Spiegel, S., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111904 · Cited by 44
Mclntyre, R. S., Nguyen, H. T., Soczynska, J. K., Lourenço, M. T. C., Woldeyohannes, H. O., & Konarski, J. Z. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.2/rsmcintyre · Cited by 41
Menon, R., & Farina, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018660 · Cited by 39
Chan, E. S., Shetty, M. S., Sajikumar, S., Chen, C., Soong, T. W., & Wong, B.-S. (2016) · Scientific Reports · doi:10.1038/srep26119 · Cited by 39
Hypothermia and Alzheimers Disease Neuropathogenic Pathways
Whittington, R. A., Papon, M.-A., Chouinard-Decorte, F., & Planel, E. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611646 · Cited by 42
Arpa, J., Sanz‐Gallego, I., Medina-Báez, J., Portela, L. V., Jardim, L. B., Torres‐Alemán, I., & Saute, J. A. M. (2010) · Movement Disorders · doi:10.1002/mds.23423 · Cited by 39
Diabetes and overweight associate with non‐APOE4 genotype in an alzheimer's disease population
Profenno, L. A., & Faraone, S. V. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30694 · Cited by 39
PPARs: a new target for neuroprotection
Bordet, R. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.077495 · Cited by 39
Macronutrients intake and risk of P arkinson's disease: A meta‐analysis
Wang, A., Lin, Y., Wu, Y., & Zhang, D. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12321 · Cited by 38
Host and Viral Factors Influencing the Pathogenesis of HIV-Associated Neurocognitive Disorders
Jayadev, S., & Garden, G. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9154-6 · Cited by 37
Endocrine Risk Factors for Cognitive Impairment
Moon, J. H. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.185 · Cited by 39
Liu, Z., Patil, I., Sancheti, H., Yin, F., & Cadenas, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-05217-z · Cited by 39
Consequences of gestational diabetes to the brain and behavior of the offspring
Sousa, R. A. L. D., TORRES, Y. S., Figueiredo, C. P., Passos, G. F., & Clarke, J. R. (2017) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201720170264 · Cited by 41
Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases
Pérez-García, A., Torrecilla-Parra, M., Frutos, M. F.-D., Martín-Martín, Y., Pardo, V., & Ramírez, C. M. (2022) · Biomolecules · doi:10.3390/biom12020208 · Cited by 45
Influence of genetic and cardiometabolic risk factors in Alzheimer’s disease
Pasqualetti, G., Thayanandan, T., & Edison, P. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101723 · Cited by 39
The Role of Gonadotropins in Alzheimer's Disease: Potential Neurodegenerative Mechanisms
Barron, A. M., Verdile, G., & Martins, R. N. (2006) · Endocrine · doi:10.1385/endo:29:2:257 · Cited by 38
Scacchi, R., Pinto, A., Gambina, G., Rosano, A., & Corbo, R. (2007) · Brain Research · doi:10.1016/j.brainres.2006.12.078 · Cited by 43
Insulin and insulin-like growth factor I signalling in neurons
Dávila, D. (2007) · Frontiers in bioscience · doi:10.2741/2306 · Cited by 38
Regulation of RAGE splicing by hn RNP A1 and Tra2β‐1 and its potential role in AD pathogenesis
Liu, X., Li, H., Su, J., Ding, F., Zhao, J., Chai, F., Li, Y., Cui, S., Sun, F., Wu, Z., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13069 · Cited by 37
Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy
Nakatsuji, H., Araki, A., Hashizume, A., Hijikata, Y., Yamada, S., Inagaki, T., Suzuki, K., Banno, H., Suga, N., Okada, Y., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8405-3 · Cited by 37
Diagnostic imaging in the management of patients with metabolic syndrome
Kim, S. R., & Lerman, L. O. (2017) · Translational research · doi:10.1016/j.trsl.2017.10.009 · Cited by 40
Kang, E., & Cho, J. Y. (2014) · Physical Activity and Nutrition · doi:10.5717/jenb.2014.18.1.89 · Cited by 37
Diabetes: Vascular or Neurodegenerative
Launer, L. J. (2008) · Stroke · doi:10.1161/strokeaha.108.533075 · Cited by 36
Lasselin, J., Layé, S., Barreau, J.-B., Rivet, A., Dulucq, M.-J., Gin, H., & Capuron, L. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.01.016 · Cited by 37
Challenges of Repurposing Tetracyclines for the Treatment of Alzheimer’s and Parkinson’s Disease
Markulin, I., Matasin, M., Turk, V. E., & Salković-Petrisic, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02457-2 · Cited by 36
Anarkooli, I. J., Ganji, H. B., & Pourheidar, M. (2014) · Journal of Diabetes Research · doi:10.1155/2014/491571 · Cited by 36
Compensatory Hippocampal Connectivity in Young Adults With Early-Stage Type 2 Diabetes
Fang, F., Lai, M., Huang, J., Kang, M., Ma, M., Li, K., Lian, J., Wang, Z., Yin, D., & Wang, Y. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02319 · Cited by 36
Therapeutic Approaches to Alzheimer’s Type of Dementia: A Focus on FGF21 Mediated Neuroprotection
Taliyan, R., Chandran, S. K., & Kakoty, V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716101411 · Cited by 35
Psychiatric Disorders - Trends and Developments
Uehara, T. (2011) · InTech eBooks · doi:10.5772/2330 · Cited by 36
Wiciński, M., Górski, K. M., Walczak, M., Wódkiewicz, E., Słupski, M., Pawlak-Osińska, K., & Malinowski, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164052 · Cited by 35
Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder
Calkin, C. (2019) · Annals of Medicine · doi:10.1080/07853890.2019.1659511 · Cited by 38
Liu, J., Zhu, B., Dong, H. Y., Zhang, Y., Xu, M., Travaš‐Sejdić, J., & Chang, Z. (2021) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2021.107995 · Cited by 35
PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease
Zimprich, A. A., Schulte, C., Reinthaler, E. M., Haubenberger, D., Balzar, J., Lichtner, P., Tawil, S. E., Edris, S., Foki, T., Pirker, W., et al. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.01.005 · Cited by 35
Hamabe, W., Fujita, R., & Ueda, H. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082735 · Cited by 35
Insulin Resistance and Cognitive Impairment
Craft, S. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1043-a · Cited by 35
Self-citationDifferential effects of intranasal insulin and caffeine on cerebral blood flow
Grichisch, Y., Çavuşoğlu, M., Preissl, H. T., Uludaǧ, K., Hallschmid, M., Birbaumer, N., Häring, H. U., Fritsche, A., & Veit, R. (2011) · Human Brain Mapping · doi:10.1002/hbm.21216 · Cited by 34
Rosenblat, J. D., Gregory, J. M., Carvalho, A. F., & McIntyre, R. S. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160126144303 · Cited by 34
Lane, R. F., Shineman, D. W., Steele, J., Lee, L. H., & Fillit, H. M. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00007-6 · Cited by 35
Regulation of intracellular HAP1 trafficking
Rong, J., Li, S., & Li, X. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21326 · Cited by 34
Beta-Amyloid Monomer and Insulin/IGF-1 Signaling in Alzheimer's Disease
Giuffrida, M. L., Tomasello, M. F., Caraci, F., Chiechio, S., Nicoletti, F., & Copani, A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8313-6 · Cited by 35
Schuh, A. F. S., Rieder, C. R. D. M., Rizzi, L., Chaves, M. L. F., & Roriz‐Cruz, M. (2011) · ISRN Neurology · doi:10.5402/2011/306905 · Cited by 34
Restless legs syndrome in dialysis patients: a meta-analysis
Mao, S., Shen, H., Huang, S., & Zhang, A. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.07.017 · Cited by 33
Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?
McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Lewis, G. F., Leiter, L. A., MacQueen, G. M., Miranda, A., Fulgosi, D., Konarski, J. Z., & Kennedy, S. H. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1615 · Cited by 32
VITALIANO, P. P. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02843.x · Cited by 30
Insulin concentration is critical in culturing human neural stem cells and neurons
Rhee, Y.-H., Choi, M. R., Lee, H.-S., Park, C.-H., Kim, S.-M., Yi, S.-H., Oh, S.-M., Cha, H.-J., Chang, M.-Y., & Lee, S.-H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.295 · Cited by 32
Geniposide decreases the level of Aβ1−42 in the hippocampus of streptozotocin-induced diabetic rats
Liu, J., Zhang, Y., Deng, X., & Yin, F. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt069 · Cited by 33
Obafemi, T. O., Olasehinde, O. R., Olaoye, O. A., Jaiyesimi, K. F., Adewumi, F. D., Adewale, O. B., & Afolabi, B. A. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00541-0 · Cited by 32
Ralbovsky, N. M., Fitzgerald, G. S., McNay, E. C., & Lednev, I. K. (2021) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2021.119603 · Cited by 32
Electrophysiological and behavioral phenotype of insulin receptor defective mice
Das, P., PARSONS, A., Scarborough, J. A., Hoffman, J., Wilson, J. M., THOMPSON, R., Overton, J. M., & Fadool, D. A. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.08.024 · Cited by 34
Risk Profiles of Alzheimer Disease
Bilbul, M., & Schipper, H. M. (2011) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012129 · Cited by 34
Targeting Insulin for Alzheimer’s Disease: Mechanisms, Status and Potential Directions
Lee, J. H., Jahrling, J. B., Denner, L. A., & Dineley, K. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179923 · Cited by 36
McFall, G. P., Wiebe, S. A., Vergote, D., Jhamandas, J. H., Westaway, D. A., & Dixon, R. A. (2014) · Psychology and Aging · doi:10.1037/a0034656 · Cited by 33
Green, H., Tsitsi, P., Markaki, I., Aarsland, D., & Svenningsson, P. (2019) · CNS Drugs · doi:10.1007/s40263-018-0601-x · Cited by 31
Bulut, E. A., Alak, Z. Y. Ş., Dokuzlar, Ö., Koçyiğit, S. E., Soysal, P., Smith, L., & Işık, A. T. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104013 · Cited by 31
Effects of Insulin and Octreotide on Memory and Growth Hormone in Alzheimer's Disease
Watson, G. S., Baker, L. D., Cholerton, B., Rhoads, K., Merriam, G. R., Schellenberg, G. D., Asthana, S., Cherrier, M. M., & Craft, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1165 · Cited by 33
Self-citationInsulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy.
Rasgon, N., Kenna, H. A., Wroolie, T., Williams, K., Demuth, B., & Silverman, D. (2014) · Psychiatry Research · doi:10.1016/j.pscychresns.2014.04.004 · Cited by 28
Lee, S. E., Han, K., Baek, J. Y., Ko, K. S., Lee, K., & Koh, E. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02774 · Cited by 31
Unwinding Complexities of Diabetic Alzheimer by Potent Novel Molecules
Gupta, S., Nair, A. B., Jhawat, V., Mustaq, N., Sharma, A., Dhanawat, M., & Khan, S. A. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317520937542 · Cited by 33
PPAR-γ Pro12Ala genotype and risk of cognitive decline in elders
Yaffe, K. S., Kanaya, A. M., Lindquist, K. J., Hsueh, W. C., Cummings, S. R., Beamer, B., Newman, A. B., Rosano, C., Li, R., & Harris, T. B. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.010 · Cited by 31
Longitudinal assessment of hippocampus structure in children with type 1 diabetes
Foland‐Ross, L. C., Reiss, A. L., Mazaika, P. K., Mauras, N., WEINZIMER, S. A., Aye, T., Tansey, M., & White, N. H. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12683 · Cited by 31
Kaiser, H. A., Hirschi, T., Sleigh, C., Reineke, D., Hartwich, V., Stucki, M., Rummel, C., SLEIGH, J. W., & Hight, D. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.06.054 · Cited by 30
Mini review: The relationship between energy status and adult hippocampal neurogenesis
Landry, T., & Hu, H. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136261 · Cited by 31
Valcour, V., Maki, P. M., Bacchetti, P., Anastos, K., Crystal, H., Young, M., Mack, W. J., Cohen, M. H., Golub, E. T., & Tien, P. C. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0159 · Cited by 30
Marano, C. M., Workman, C. I., Lyman, C. H., Kramer, E., Hermann, C. R., Ma, Y., DHAWAN, V. M., Chaly, T., Eidelberg, D., & Smith, G. S. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.01.009 · Cited by 30
ElBatsh, M. M., El‐Batch, M., Shafik, N. M., & Younos, I. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.033 · Cited by 31
Gasperi, R. D., Sosa, M. A. G., Dracheva, S. M., & Elder, G. A. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-38 · Cited by 31
The Additive Effects of Type-2 Diabetes on Cognitive Function in Older Adults with Heart Failure
Alosco, M. L., Spitznagel, M. B., van Dulmen, M. H. M., Raz, N., Cohen, R. A., Sweet, L. H., Colbert, L. H., Josephson, R., Hughes, J. W., Rosneck, J., et al. (2012) · Cardiology Research and Practice · doi:10.1155/2012/348054 · Cited by 29
Metadata
- Authors
- Craft, S., & Stennis Watson, G.
- Affiliations
- University of Washington (US)
- Corresponding author
- Craft, Suzanne
- ORCID
- Craft, Suzanne
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 3
- Issue
- 3
- Pages
- 169-178
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2145451941
- Cited by
- 830
- References
- 145
- Citations by year
- 2026: 17 · 2025: 26 · 2024: 29 · 2023: 37 · 2022: 36 · 2021: 27 · 2020: 49 · 2019: 42 · 2018: 36 · 2017: 36 · 2016: 43 · 2015: 37 · 2014: 66 · 2013: 44 · 2012: 48
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01-AG-10880, R01AG010880)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK061606, DK61606)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- insulin, neurodegenerative diseases, brain insulin signaling, Alzheimer's disease, vascular dementia, Parkinson's disease, Huntington's disease, insulin dysregulation, late-life cognitive decline
- MeSH terms
- Animals, Brain, Cognition Disorders, Diabetes Mellitus, Energy Metabolism, Humans, Insulin, Receptor, Insulin, Signal Transduction, Neurodegenerative Diseases, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review